China’s local governments are combating COVID-19 with unprecedented responses ---- from a Wenzhou governance perspective

doi:10.1007/s11684-020-0755-z

Front. Med.

2020, Vol. 14

Issue (2) : 220-224 https://doi.org/10.1007/s11684-020-0755-z

COMMENTARY

China’s local governments are combating COVID-19 with unprecedented responses ---- from a Wenzhou governance perspective

Fanghua Gong^1,², Yong Xiong², Jian Xiao^1,², Li Lin^1,², Xiaodong Liu³, Dezhong Wang², Xiaokun Li^1,²(

)

¹. School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China
². Biomedicine Collaborative Innovation Center, Wenzhou 325035, China
³. School of Public Health and Management, Wenzhou Medical University, Wenzhou 325035, China

Download: PDF(458 KB) HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Abstract

The COVID-19 caused by a novel strain of coronavirus has been spreading rapidly since its occurrence in December 2019. It is highly communicable through human-to-human transmission. China has been making unprecedented efforts in treating the confirmed cases, identifying and isolating their close contacts and suspected cases to control the source of infection and cut the route of transmission. China’s devotion in handling this epidemic has effectively and efficiently curbed communication domestically and across the border. Representative measures adopted by Wenzhou, the worst hit city out of Hubei Province, are examined to elucidate those massive undertakings with the aim of enhancing international understanding and building global rapport in fighting this evolving epidemic situation.

Keywords COVID-19 novel coronavirus pneumonia 2019-nCoV epidemic management

Corresponding Author(s): Xiaokun Li

Just Accepted Date: 13 February 2020 Online First Date: 12 March 2020 Issue Date: 09 May 2020

Cite this article:

Fanghua Gong,Yong Xiong,Jian Xiao, et al. China’s local governments are combating COVID-19 with unprecedented responses ---- from a Wenzhou governance perspective[J]. Front. Med., 2020, 14(2): 220-224.

URL:

https://academic.hep.com.cn/fmd/EN/10.1007/s11684-020-0755-z
https://academic.hep.com.cn/fmd/EN/Y2020/V14/I2/220

Fig.1 Trend of confirmed COVID-19 cases in Chinese mainland from January 24 to February 11, 2020 (Data source: Official website of National Health Commission of the People’s Republic of China).

Fig.2 Trend of suspected COVID-19 cases in Chinese mainland from January 24 to February 11, 2020 (Data source: Official website of National Health Commission of the People’s Republic of China).

Fig.3 Trend of COVID-19-caused deaths in Chinese mainland from January 24 to February 11, 2020 (Data source: Official website of National Health Commission of the People’s Republic of China).

Fig.4 Number of traced close contacts with COVID-19 patients or suspects and those subsequently placed under medical observation in Wenzhou from January 26 to February 11, 2020 (Data source: Official website of Wenzhou Municipal People’s Government).

Fig.5 Number of confirmed COVID-19 cases in Wenzhou from January 24 to February 11, 2020 (Data source: Official website of Wenzhou Municipal People’s Government).

1	National Health Commission of the People’s Republic of China. Notice by National Health Commission on the Provisional Designation of Novel Coronavirus Pneumonia. 2020. (in Chinese) (accessed February 8, 2020)
2	World Health Organization. Novel Coronavirus (2019-nCoV) Situation Report – 22. 2020. (accessed February 12, 2020)
3	World Health Organization. WHO Director-General’s statement on IHR Emergency Committee on Novel Coronavirus (2019-nCoV). 2020. (accessed February 3, 2020)
4	National Health Commission of the People’s Republic of China. Latest update on Novel Coronavirus Pneumonia as of 24:00, February 11, 2020. 2020. (in Chinese) (accessed February 12, 2020)
5	Tencent News. Real-time update: Latest on COVID-19. 2020. (in Chinese) (accessed February 12, 2020)
6	XINHUA. Makeshift hospital in Wuhan receives coronavirus-infected patients. 2020. (accessed February 8, 2020)
7	Wenzhou Municipal Health Commission. Fight ten days for the inflection point! Wenzhou sounds the bugle call to beat epidemic spread. 2020. (in Chinese) (accessed February 3, 2020)
8	XINHUA. Commanding China’s fight against novel coronavirus outbreak. 2020. (accessed February 3, 2020)

[1]	Zixin Shu, Yana Zhou, Kai Chang, Jifen Liu, Xiaojun Min, Qing Zhang, Jing Sun, Yajuan Xiong, Qunsheng Zou, Qiguang Zheng, Jinghui Ji, Josiah Poon, Baoyan Liu, Xuezhong Zhou, Xiaodong Li. Clinical features and the traditional Chinese medicine therapeutic characteristics of 293 COVID-19 inpatient cases[J]. Front. Med., 2020, 14(6): 760-775.
[2]	Guohua Chen, Wen Su, Jiayao Yang, Dan Luo, Ping Xia, Wen Jia, Xiuyang Li, Chuan Wang, Suping Lang, Qingbin Meng, Ying Zhang, Yuhe Ke, An Fan, Shuo Yang, Yujiao Zheng, Xuepeng Fan, Jie Qiao, Fengmei Lian, Li Wei, Xiaolin Tong. Chinese herbal medicine reduces mortality in patients with severe and critical coronavirus disease 2019: a retrospective cohort study[J]. Front. Med., 2020, 14(6): 752-759.
[3]	Qingwei Li, Han Wang, Xiuyang Li, Yujiao Zheng, Yu Wei, Pei Zhang, Qiyou Ding, Jiaran Lin, Shuang Tang, Yikun Zhao, Linhua Zhao, Xiaolin Tong. The role played by traditional Chinese medicine in preventing and treating COVID-19 in China[J]. Front. Med., 2020, 14(5): 681-688.
[4]	Mian Peng, Xueyan Liu, Jinxiu Li, Di Ren, Yongfeng Liu, Xi Meng, Yansi Lyu, Ronglin Chen, Baojun Yu, Weixiong Zhong. Successful management of seven cases of critical COVID-19 with early noninvasive–invasive sequential ventilation algorithm and bundle pharmacotherapy[J]. Front. Med., 2020, 14(5): 674-680.
[5]	Lingling Tang, Yingan Jiang, Mengfei Zhu, Lijun Chen, Xiaoyang Zhou, Chenliang Zhou, Peng Ye, Xiaobei Chen, Baohong Wang, Zhenyu Xu, Qiang Zhang, Xiaowei Xu, Hainv Gao, Xiaojun Wu, Dong Li, Wanli Jiang, Jingjing Qu, Charlie Xiang, Lanjuan Li. Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19[J]. Front. Med., 2020, 14(5): 664-673.
[6]	Zhihang Peng, Wenyu Song, Zhongxing Ding, Quanquan Guan, Xu Yang, Qiaoqiao Xu, Xu Wang, Yankai Xia. Linking key intervention timings to rapid declining effective reproduction number to quantify lessons against COVID-19[J]. Front. Med., 2020, 14(5): 623-629.
[7]	Chen Xu, Yinqiao Dong, Xiaoyue Yu, Huwen Wang, Lhakpa Tsamlag, Shuxian Zhang, Ruijie Chang, Zezhou Wang, Yuelin Yu, Rusi Long, Ying Wang, Gang Xu, Tian Shen, Suping Wang, Xinxin Zhang, Hui Wang, Yong Cai. Estimation of reproduction numbers of COVID-19 in typical countries and epidemic trends under different prevention and control scenarios[J]. Front. Med., 2020, 14(5): 613-622.
[8]	Jiuyang Xu, Chaolin Huang, Guohui Fan, Zhibo Liu, Lianhan Shang, Fei Zhou, Yeming Wang, Jiapei Yu, Luning Yang, Ke Xie, Zhisheng Huang, Lixue Huang, Xiaoying Gu, Hui Li, Yi Zhang, Yimin Wang, Frederick G. Hayden, Peter W. Horby, Bin Cao, Chen Wang. Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis[J]. Front. Med., 2020, 14(5): 601-612.
[9]	Zhengqian Li, Taotao Liu, Ning Yang, Dengyang Han, Xinning Mi, Yue Li, Kaixi Liu, Alain Vuylsteke, Hongbing Xiang, Xiangyang Guo. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain[J]. Front. Med., 2020, 14(5): 533-541.
[10]	Cenyi Shao, Shijian Li, Feng Zhu, Dahai Zhao, Hui Shao, Haixiao Chen, Zhiruo Zhang. Taizhou’s COVID-19 prevention and control experience with telemedicine features[J]. Front. Med., 2020, 14(4): 506-510.
[11]	Guangbiao Zhou, Saijuan Chen, Zhu Chen. Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies[J]. Front. Med., 2020, 14(2): 117-125.
[12]	Yong Li, Fan He, Ning Zhou, Jia Wei, Zeyang Ding, Luyun Wang, Peng Chen, Shuiming Guo, Binhao Zhang, Xiaoning Wan, Wei Zhu, on behalf of Multidisciplinary Team for COVID-19, Optical Valley Branch of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Organ function support in patients with coronavirus disease 2019: Tongji experience[J]. Front. Med., 2020, 14(2): 232-248.
[13]	Zhiruo Zhang, Shelan Liu, Mi Xiang, Shijian Li, Dahai Zhao, Chaolin Huang, Saijuan Chen. Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions[J]. Front. Med., 2020, 14(2): 229-231.
[14]	Jiuyang Xu, Yijun Chen, Hao Chen, Bin Cao. 2019 novel coronavirus outbreak: a quiz or final exam?[J]. Front. Med., 2020, 14(2): 225-228.
[15]	Shuxian Zhang, Zezhou Wang, Ruijie Chang, Huwen Wang, Chen Xu, Xiaoyue Yu, Lhakpa Tsamlag, Yinqiao Dong, Hui Wang, Yong Cai. COVID-19 containment: China provides important lessons for global response[J]. Front. Med., 2020, 14(2): 215-219.

Viewed

Full text

Abstract

Cited

Shared

Discussed